First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping

Agdamag, Arianne Clare; Shaffer, Andrew; Wechsler, Andrew S.; Pritzker, Marc; Fraser, Meg; Martin, Cindy M.; Cogswell, Rebecca; Alexy, Tamás

doi:10.1016/j.athoracsur.2020.11.052

Cited by 3 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…118 On the contrary, the Revinent TC System (BioVentrix Inc) provides a less invasive approach for altering LV dimensions in selected HF patients with ischemic cardiomyopathy. 119 Cardiac surgical procedures such as the Batista procedure, partial left ventriculectomy, and skeletal muscle cardiomyoplasty are rarely used nowadays in the management of end-stage HF as a bridge to cardiac transplantation. 120 121…”

Section: Managementmentioning

confidence: 99%

Pathophysiology and Management of Heart Failure in the Elderly

et al. 2022

View full text Add to dashboard Cite

The population of elderly adults is increasing globally. It has been projected that the population of adults aged 65 years will increase by approximately 80% by 2050 in the United States. Similarly, the elderly population is rising in other countries; a notable example being Japan where approximately 30% of the population are aged above 65 years. The pathophysiology and management of heart failure (HF) in this age group tend to have more intricacies than in younger age groups owing to the presence of multiple comorbidities. The normal aging biology includes progressive disruption at cellular and genetic levels and changes in molecular signaling and mechanical activities that contribute to myocardial abnormalities. Older adults with HF secondary to ischemic or valvular heart disease may benefit from surgical therapy, valve replacement or repair for valvular heart disease and coronary artery bypass grafting for coronary artery disease. While referring these patients for surgery, patient and family expectations and life expectations should be taken into account. In this review, we will cover the pathophysiology and the management of HF in the elderly, specifically discussing important geriatric domains such as frailty, cognitive impairment, delirium, polypharmacy, and multimorbidity.

show abstract

Section: Managementmentioning

confidence: 99%

Pathophysiology and Management of Heart Failure in the Elderly

et al. 2022

View full text Add to dashboard Cite

show abstract

LIVE™ – eine innovative Option zur minimal-invasiven Infarkttherapie durch operative Ventrikelrekonstruktion ohne Herz-Lungen-Maschine

Popov

Hanke

2022

Z Herz- Thorax- Gefäßchir

View full text Add to dashboard Cite

Interventional heart failure therapy: A new concept fighting against heart failure

Saku

Yokota

Nishikawa

et al. 2022

Journal of Cardiology

View full text Add to dashboard Cite

Heart failure is a progressive disease that is associated with repeated exacerbations and hospitalizations. The rapid increase in the number of heart failure patients is a global health problem known as the 'heart failure pandemic'. To control the pandemic, multifaceted approaches are essential, ranging from prevention of onset to long-term disease management. Especially in patients with moderate to severe heart failure (stages C and D), surgical and catheter-based interventions are prerequisites for saving lives, preserving cardiac function, improving quality of life (QOL), and prognosis. In addition, various new medical technologies for these interventions have been clinically applied and have been shown to be effective against symptoms and improve the QOL and prognosis of patients with heart failure. Furthermore, the concept of interventional heart failure (IHF) therapy, which considers heart recovery and prevention of worsening of heart failure via multidisciplinary treatment using surgical, catheter interventions, and mechanical circulatory support devices, has been proposed worldwide. This review discusses the importance of IHF therapy in heart failure management, recent changes in interventional technologies and strategies for patients with heart failure, and worldwide education attempts for IHF specialists.

show abstract

First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping

Cited by 3 publications

References 3 publications

Pathophysiology and Management of Heart Failure in the Elderly

Pathophysiology and Management of Heart Failure in the Elderly

LIVE™ – eine innovative Option zur minimal-invasiven Infarkttherapie durch operative Ventrikelrekonstruktion ohne Herz-Lungen-Maschine

Interventional heart failure therapy: A new concept fighting against heart failure

Contact Info

Product

Resources

About